Pain Control for Anterior Cruciate Ligament Reconstruction Patients With Adductor Canal or Femoral Perineural Infusions
Pain, Postoperative, Anterior Cruciate Ligament Injury
About this trial
This is an interventional treatment trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- Adult patients >18 years
- ASA physical status I, II, or III
- Scheduled for ACL reconstruction surgery with patellar autograft
Exclusion Criteria:
- Pregnancy
- Incarceration
- Age <18
- BMI >35
- Pre-operative opioid use >15 mg morphine equivalents per day
- Inability to communicate with investigators by telephone
- Pre-existing neuropathy of the operative extremity
Sites / Locations
- Stanford University
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Adductor Canal Nerve Block group
Femoral Nerve Block group
Adductor Canal perineural catheter placement. Adductor Canal continuous perineural infusion. Ropivacaine 0.2% will be administered at a continuous rate of 5 mL/hour through a perineural catheter placed in the adductor canal. A Nimbus pump (Infutronix) will be delivering the medication.
Femoral Nerve perineural catheter placement. Femoral continuous perineural infusion. Ropivacaine 0.2% will be administered at a continuous rate of 5 mL/hour through a perineural catheter placed near the femoral nerve. A Nimbus pump (Infutronix) will be delivering the medication.